2021 RBC Innovation & Entrepreneurship Prize Finalists

Join us at our largest startup pitch competition of the year, offering $50,000+ in prizes to recognize, reward, and accelerate the University of Toronto’s most innovative startups.

When: Tuesday, March 9, 2021, 2 – 4 pm EST (Toronto)

Where: U of T Entrepreneurship Week (virtual)

Why: Ten top startups from across the entire U of T ecosystem will have only three minutes to speed-pitch their business idea to an impressive judging panel for $50,000+ in prizes. And the best part? The funding is non-dilutive!

Early Stage Prizes:

  • 1st Prize: $10,000
  • 2nd Prize: $5,000
  • Dongjun Wang Family True Blue Prize (People’s Choice): $4,000

Later Stage Prizes:

  • 1st Prize: $25,000
  • 2nd Prize: $10,000
  • Dongjun Wang Family True Blue Prize (People’s Choice): $4,000

 

Early Stage Competition: 2:00 – 3:00 pm

Elaya is a medical device-based solution that delivers neuromuscular electrical stimulation in the hospital ICU. Elaya will solve the challenges of stimulation pad application and will scale therapist resources to deliver therapy to multiple patients to combat ICU-Acquired Weakness.

Exvilent offers a novel humanized ex vivo lung model that provides the most existing physiologically relevant research tool to achieve precision medicine, thereby reducing research attrition rate and turnaround time while promoting animal conservatism. Learn more.

Fyyne is a mobile-first platform that allows hair artists to run their businesses more effectively and efficiently using their proprietary technology to connect relevant artists with customers and simplify the entire booking process from discovery to payment. Learn more.

Infera offers an AI platform for digital twins that allows engineers to leverage computational models to inform every stage of a product lifecycle from design through manufacturing, deployment, and decommissioning. The software platform uses our statistically rigorous patented technology to build digital twins and to leverage them to inform decision-making in the presence of uncertainty. Learn more.

NerveX Neurotechnologies is developing ANIMO, the Adaptive Neural Implant for Modulation and Observation of the nervous system’s communication superhighway: the vagus nerve (or cranial nerve X). ANIMO will first be deployed in the veterinary market to treat canine epilepsy which affects ~7.5M pet dogs in North America alone. Learn more.

Later Stage Competition: 3:00 – 4:00 pm

ALT TEX is a Toronto-based biomaterials startup, creating biodegradable and carbon neutral textiles re-engineered from food waste. ALT TEX’s highly scalable solution offers polyester-like performance, enabling brands to offer sustainable solutions without sacrificing quality. Learn more.

Revolve Surgical is developing a new type of surgical robotics for minimally invasive procedures that is an order of magnitude cheaper and smaller than existing systems. Revolve’s mission is to bring the benefits of surgical robotics to patients globally. Learn more.

Shiphrah Biomedical developed a wearable musculoskeletal support and positional therapy device for healthy pregnant women in their third trimester who have difficulty sleeping soundly and safely. Learn more.

StarSpec offers a rapidly deployable, plug-and-play satellite bus capable of providing space qualification, in situ instrument testing and operations at 10% of the traditional industry cost. Learn more.

TissueCraft offers a patented engineered human heart tissue screening platform for academic and industry labs developing therapeutics. The platform enhances screening strategies related to cardiac drug discovery, cardiotoxicity, and the development of cell-based therapies to treat heart disease. 

Panelists

Steph Morgan
Head, Mobility Ventures
RBC Ventures

Jason Baibokas
Principal
KASCorp

Jeannette Wiltse
Partner & CFO
Relay Ventures

Nuha Siddiqui
Co-founder & CEO
Erthos

Learn more about the RBC Prize for Innovation & Entrepreneurship and our other funding opportunities.